Nuvectis Pharma Inc
(NVCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,757 | -4,049 | -19,085 | -12,389 | -6,512 |
| Other Working Capital | -1,455 | -2,130 | 3,819 | 1,121 | 227 |
| Other Operating Activity | 2,352 | 1,402 | 1,707 | 1,225 | 666 |
| Operating Cash Flow | $-8,860 | $-4,777 | $-13,559 | $-10,043 | $-5,619 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,440 | 702 | 31,879 | 31,879 | 16,000 |
| Other Financing Activity | -973 | -450 | -4,069 | -3,938 | -2,551 |
| Financing Cash Flow | $13,467 | $252 | $27,810 | $27,941 | $13,449 |
| Beginning Cash Position | 19,993 | 19,993 | 5,742 | 5,742 | 5,742 |
| End Cash Position | 24,600 | 15,468 | 19,993 | 23,640 | 13,572 |
| Net Cash Flow | $4,607 | $-4,525 | $14,251 | $17,898 | $7,830 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,860 | -4,777 | -13,559 | -10,043 | -5,619 |
| Free Cash Flow | -8,860 | -4,777 | -13,559 | -10,043 | -5,619 |